Early HCV viral kinetics after liver transplantation

被引:0
|
作者
García-Retortillo, M [1 ]
Forns, X [1 ]
Feliu, A [1 ]
Moitinho, E [1 ]
Costa, J [1 ]
Mas, A [1 ]
Grande, L [1 ]
Navasa, M [1 ]
Rodés, J [1 ]
机构
[1] Hosp Clin Barcelona, Liver Unit, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:9 / 9
页数:1
相关论文
共 50 条
  • [31] Complications of HCV treatment after liver transplantation.
    Pawlowska, Joanna
    Teisseyre, Mikolaj
    Jankowska, Irena
    Kalicinski, Piotr
    Dzierzanowska-Fangrat, Katarzyna
    Kluge, Przeinyslaw
    Teisseyre, Joanna
    Socha, Jerzy
    Woynarowski, Marek
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 93 - 93
  • [32] Successful Continuation of HCV Treatment After Liver Transplantation
    Fernandez Carrillo, Carlos
    Crespo, Gonzalo
    de la Revilla, Juan
    Castells, Lluis
    Buti, Maria
    Luis Montero, Jose
    Fabrega, Emilio
    Fernandez, Inmaculada
    Serrano-Millan, Cristina
    Hernandez, Victoria
    Luis Calleja, Jose
    Londono, Maria-Carlota
    TRANSPLANTATION, 2017, 101 (05) : 1009 - 1012
  • [33] IMMUNOSUPPRESSION FOR HCV INFECTED PATIENTS AFTER LIVER TRANSPLANTATION
    Merhav, Hadar J.
    Mieles, Luis
    Saggi, Boh H.
    Ottman, Misty
    Ekpo, Nse
    Botero, Claudino R.
    LIVER TRANSPLANTATION, 2008, 14 (07) : S113 - S114
  • [34] TREATMENT FOR RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION
    Guedes, Cassia
    Pousa, Fernanda
    Roma, Joyce
    Gonzalez, Ana Carolina
    Agolia, Luciana
    Enne, Marcelo
    Martinho, Jose Manoel
    Carius, Luciana
    Balbi, Elizabeth
    Pacheco-Moreira, Lucio
    LIVER TRANSPLANTATION, 2009, 15 (07) : S131 - S131
  • [35] Hepatitis C virus (HCV) kinetics and quasispecies evolution during and immediately after liver transplantation.
    Forns, X
    Garcia, M
    Feliu, A
    Moitinho, E
    Costa, J
    Navasa, M
    Rodes, J
    HEPATOLOGY, 2001, 34 (04) : 362A - 362A
  • [36] Feasibility and Benefit of Minimization and Withdrawal of Immunosuppression (IS) Early After Liver Transplantation in HCV Positive Recipients
    Shaked, A.
    Feng, S.
    Punch, J.
    Reyes, J.
    Klintmalm, G.
    Zimmerman, M.
    DesMarais, M.
    Kopetskie, H.
    Priore, A.
    Bridges, N.
    Sayre, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 230 - 231
  • [37] Early evaluation of regulatory T cells to predict severity of HCV recurrence after liver transplantation
    Ghazal, Kaldoun
    Olivier, Morales
    Barjon, Clement
    Dahlqvist, Geraldine
    Aoudjehane, Lynda
    Ouaguia, Laurissa
    Calmus, Yvon
    Nadira, Delhem
    Conti, Filomena
    HEPATOLOGY, 2014, 60 : 461A - 461A
  • [38] Early periportal sinusoidal fibrosis is an accurate marker of accelerated HCV recurrence after liver transplantation
    Marino, Zoe
    Mensa, Laura
    Crespo, Gonzalo
    Miquel, Rosa
    Bruguera, Miquel
    Perez-del-Pulgar, Sofia
    Bosch, Jaume
    Forns, Xavier
    Navasa, Miquel
    JOURNAL OF HEPATOLOGY, 2014, 61 (02) : 270 - 277
  • [39] HCV GENOTYPES AND QUANTITATION OF HCV RNA - RELATIONSHIP WITH HCV RECURRENCE AFTER LIVER-TRANSPLANTATION
    PAGEAUX, GP
    DUCOS, J
    COSTE, V
    MONDAIN, AM
    FABRE, JM
    DOMERGUE, J
    LARREY, D
    SERRE, A
    MICHEL, H
    HEPATOLOGY, 1995, 22 (04) : 109 - 109
  • [40] HCV and Liver Transplantation
    Kaplan A.
    Brown R.S., Jr.
    Current Hepatology Reports, 2021, 20 (4) : 191 - 197